Cedar Honey in Oral Lichen Planus
Phase 1
Completed
- Conditions
- Erosive and Atrophic Oral Lichen Planus
- Interventions
- Drug: orally administered cedar honey
- Registration Number
- NCT01974414
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
The study aimed to evaluate the effect of cedar honey in treatment of erosive and atrophic oral lichen planus ( a common oral problem).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
- clinically and histopathologically confirmed oral lichen planus without dysplasia in histopathologic evaluation
- Severity of pain≥2 (VAS score)
- Severity of lesions≥2 (tong prasom criteria)
- absence of any treatment in the last month
- absence of kidney or liver diseases( due to systemic administration of fluconazole to both groups)
Read More
Exclusion Criteria
- evidence of lichenoid reaction in clinical or histopathologic assessment
- loss of follow up
- pregnant patients
- diabetic patients
- any other mucosal disease
- any severe systemic disease
- patients who refuse doctor's advice
- any unexpected adverse effect of honey
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description cedar honey orally administered cedar honey The two study groups were provided with standard treatment(dexamethasone and Fluconazole).The Case group(A) received cedar honey, 20 ml 3 times daily by swish and swallow technique, in addition to the standard treatment .
- Primary Outcome Measures
Name Time Method severity of lesions 4 weeks severity of lesions due to thong prasom criteria
- Secondary Outcome Measures
Name Time Method size of lesions 4 weeks A sterile caulis was used to measure the maximum diameter of erosive and atrophic lesions and the maximum width perpendicular to the maximum diameter was recorded.
Trial Locations
- Locations (1)
Oral Medicine Department of Mashhad dental School,Oral and Maxillofacial diseases research center
🇮🇷Mashhad, Khorasan Razavi, Iran, Islamic Republic of